Differential expression of estrogen receptor subtypes and variants in ovarian cancer: effects on cell invasion, proliferation and prognosis

BACKGROUND: Due to the presence of both classical estrogen receptor (ERα) and another ER subtype (ERβ) in ovarian cancer, hormonal treatment is an attractive option. However, response to tamoxifen in ovarian cancer is modest. The presence of ERβ variants further complicated the issue. We have recent...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Chan, Karen K. L., Siu, Michelle K. Y., Jiang, Yu-xin, Wang, Jing-jing, Wang, Yan, Leung, Thomas H. Y., Liu, Stephanie S., Cheung, Annie N. Y., Ngan, Hextan Y. S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5579953/
https://ncbi.nlm.nih.gov/pubmed/28859612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3601-1
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi